Masayuki Miyano
Company: Eisai
Job title: Principal Scientist
Seminars:
Delivery of BET Protein Degrader to Pancreatic Cancer & Their Microenvironment Via CEACAM6-Targeted Antibody–Drug Conjugate 11:30 am
Analyzing Antibody protein degrader conjugate Understanding pancreatic cancer and its effects Reviewing a novel payload, BET protein degraderRead more
day: Day Two